Sumatriptan treatment for migraine in a health maintenance organization: Economic, humanistic, and clinical outcomes

Cohen, Jeffrey A.; Beall, Donna G.; Beck, Arne; Rawlings, Julia E.; Miller, David W.; Clements, Bill; Pait, D. Gayla; Batenhorst, Alice S.

doi:10.1016/s0149-2918(00)88278-8

Cited by 48 publications

(37 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…42 Studies have also shown that effective treatment of migraine has a positive impact on health-related quality of life. 13,14,19,23,26 Other studies have described the cost-effectiveness of migraine treatment. 43,44 Several of the publications that met the inclusion criteria for this review of workplace productivity also described results from quality-of-life questionnaires.…”

Section: Discussionmentioning

confidence: 99%

“…43,44 Several of the publications that met the inclusion criteria for this review of workplace productivity also described results from quality-of-life questionnaires. 13,14,18,19,21,23,26,28,35 The current study focuses on the impact of migraine and migraine treatment on worker productivity, a topic of interest to employers, health care decision makers, physicians, and patients. Worker productivity is 1 component of the overall impact of migraine.…”

Section: Discussionmentioning

confidence: 99%

“…This finding suggests that the mean values for productivity loss may be affected by outlier individuals who are reporting high levels of productivity loss. 13,14,16,18,19,22,23,25,26 Individuals who initiated triptan therapy were asked to report the impact of migraine on work productivity while treating headaches with usual therapy (pretest) and after initiating triptan therapy (posttest). However, usual therapy was not defined by the study protocol.…”

Section: Placebo-controlled Randomized Studies Evaluating the Effect mentioning

confidence: 99%

“…Five of the 8 pretest and posttest studies evaluated migraine with a recall period ranging from 1 month to 12 months. 14,18,19,22,23 Workplace productivity data were collected from 1 to 12 months after initiation of triptan therapy. Legg et al 22 included all migraineurs who received at least 1 dose of sumatriptan in the treatment results.…”

Section: Placebo-controlled Randomized Studies Evaluating the Effect mentioning

confidence: 99%

“…15,16,18,19,21,25,26,29,31 Four studies allowed patients to treat migraine when pain was at any severity level from mild, moderate, or severe. 13,14,22,23 None of the studies that met our inclusion criteria for the current literature review compared productivity loss in migraineurs who were instructed to treat migraine headaches limited to mild pain.…”

Section: Placebo-controlled Randomized Studies Evaluating the Effect mentioning

confidence: 99%

See 4 more Smart Citations

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

Burton

Landy

Downs

et al. 2009

Mayo Clinic Proceedings

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Placebo-controlled Randomized Studies Evaluating the Effect mentioning

confidence: 99%

Section: Placebo-controlled Randomized Studies Evaluating the Effect mentioning

confidence: 99%

Section: Placebo-controlled Randomized Studies Evaluating the Effect mentioning

confidence: 99%

See 3 more Smart Citations

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

Burton

Landy

Downs

et al. 2009

Mayo Clinic Proceedings

View full text Add to dashboard Cite

Inter-Provincial Variation in Government Drug Formularies

Grégoire

MacNeil

Skilton

et al. 2001

Can J Public Health

View full text Add to dashboard Cite

Acute treatment of migraine and the role of triptans

Freitag

2001

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

The use of triptans has improved the ability to treat migraine successfully compared with older treatments. Speed of relief, consistency of effect, and good tolerability have been the hallmarks of these agents. All of the currently available triptans have comparable efficacy and tolerability. Variables between the agents may lead to one agent or dose form being preferred over another in various clinical scenarios. The triptans that are forthcoming may improve on these options through enhanced efficacy rates, tolerability, and headache recurrence rates. There exist increasing options for migraine treatment that may further improve the clinical effects of the older and newer triptans through early treatment of migraine at the stages of mild migraine pain, or even during the prodromal phase of the attack. Additionally, recent work suggests that mini-prophylaxis of migraine at the menses is a highly successful treatment option with the triptans. In this age of managed care, providing cost-effective treatment of headache will take on increasing importance. Techniques such as stratification of acute treatments may enhance cost-effective care, whereas ready availability of the triptans may lead to significant improvements in utilization of parameters such as office visits, emergency room treatment, and even hospitalization.

show abstract

Sumatriptan treatment for migraine in a health maintenance organization: Economic, humanistic, and clinical outcomes

Cited by 48 publications

References 18 publications

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

Inter-Provincial Variation in Government Drug Formularies

Acute treatment of migraine and the role of triptans

Contact Info

Product

Resources

About